Rachael Hui Riong Pung - Epidemiology

Author Information

Rachael Hui Riong Pung is affiliated with the Ministry of Health, Singapore, and holds multiple positions at the London School of Hygiene & Tropical Medicine, London, UK, including the Centre for the Mathematical Modelling of Infectious Diseases and the Department of Infectious Disease Epidemiology. Her research primarily focuses on infectious disease epidemiology, with a significant emphasis on COVID-19 and related public health challenges.

Research Contributions

Rachael Hui Riong Pung has made substantial contributions to the field of epidemiology, particularly in the context of the COVID-19 pandemic. Her work involves statistical modeling, assessment of outbreak control measures, and the evaluation of vaccine efficacy. Notable studies include the evaluation of methods for forecasting COVID-19 hospital admissions, the impact of pandemic-related disruptions on dengue transmission, and the effectiveness of different vaccine boosters against COVID-19. Additionally, she has conducted significant research on the transmission dynamics of SARS-CoV-2 variants and the implications of public health interventions in densely populated settings.

Aliases

Rachael Hui Riong Pung is also known by the following aliases: R. Pung, R Pung, and Rachael Pung.

Publication and Citation Metrics

Metric	Value
Total Citations	1550
H-Index	12
Paper Count	36

Publications:

Comparative assessment of methods for short-term forecasts of COVID-19 hospital admissions in England at the local level

DOI: 10.1186/s12916-022-02271-x

Year: 2022

Measuring the effects of COVID-19-related disruption on dengue transmission in southeast Asia and Latin America: a statistical modelling study

DOI: 10.1016/S1473-3099(22)00025-1

Year: 2022

Association of Homologous and Heterologous Vaccine Boosters With COVID-19 Incidence and Severity in Singapore.

DOI: 10.1001/jama.2022.1922

Year: 2022

Using high-resolution contact networks to evaluate SARS-CoV-2 transmission and control in large-scale multi-day events.

DOI: 10.1038/s41467-022-29522-y

Year: 2022

The potential for vaccination-induced herd immunity against the SARS-CoV-2 B.1.1.7 variant

DOI: 10.2807/1560-7917.ES.2021.26.20.2100428

Year: 2021

Serial intervals in SARS-CoV-2 B.1.617.2 variant cases

DOI: 10.1016/S0140-6736(21)01697-4

Year: 2021

Factors influencing SARS-CoV-2 transmission and outbreak control measures in densely populated settings

DOI: 10.1038/s41598-021-94463-3

Year: 2021

Relative role of border restrictions, case finding and contact tracing in controlling SARS-CoV-2 in the presence of undetected transmission

DOI: 10.1101/2021.05.05.21256675

Year: 2021

Using high-resolution contact networks to evaluate SARS-CoV-2 transmission and control in large-scale multi-day events

DOI: 10.1101/2021.11.12.21266183

Year: 2021

Association of SARS-CoV-2 clades with clinical, inflammatory and virologic outcomes: An observational study

DOI: 10.1016/j.ebiom.2021.103319

Year: 2021

Why is Needle Sharing a Public Health Concern?

What is the Difference Between Attack Rate and Incidence Rate?

What Factors Influence the Success of EBIs?

What Are Some Challenges in Achieving Health Equity in Epidemiology?

Why Study Ethnic Minorities in Epidemiology?

What are Some Successful Examples of Partnerships in Epidemiology?

What is a Common Source Epidemic?

Why is ERB Approval a Requirement for Publication?

Can Slip Slop Slap be Applied Globally?

What Are the Ethical Considerations Regarding Patient Records?

Partnered Content Networks

Relevant Topics